Lloyd's Law Reports: Pharma

Lloyd's Law Reports: Pharma is the ultimateand lawyer Axel Schulz. Ian has worked with, among
pharmaceutical and biotechnology case law researchothers, GlaxoSmithKline and Pfizer. Axel also focuses
tool enabling you to keep up to date on importanton the pharma industry, advising on distribution,
changes and developments in case law as theyco-marketing and licensing. Their team includes IP and
happen.regulatory affairs specialists from across Europe.
Subscription includes :Clear, concise and completely relevant - Each case
Online access to the case-reporting servicereport contains keywords and clear, concise
Case archivesummary headnotes explaining the case, so you'll
Quarterly print edition of selected casesknow instantly why it's relevant to you. Every set of
E-mail alert service telling you when new case reportsheadnotes includes a complete history of the case to
are onlinedate, a point-by-point breakdown of the judgment
Legal specialists in the life sciences - Our case reportsand, where necessary, the relevant scientific
are chosen and written by barristers and lawyersbackground explained by experts. Our exclusive focus
specialising in the life sciences. Our Editor-in-chief,on pharma means you never pay for information you
Christopher Floyd, QC, is one of the UK's leadingdon't need.
barristers in IP and life sciences. Kathryn Pickard, aJurisdictions covered by Lloyd's Law Reports: Pharma
barrister and our UK Editor, is also an IP and pharma- Our case reports cover selected European
specialist.jurisdictions, as well as the ECJ, EPO an the
Our EU Editors from White & Case are Ian Forrester,UK.Territories include Germany, France and the Czech
a QC with an exceptional record in competition law,Republic. Full judgments are provided in every case.